|
Claims  |
|
|
We claim:
1. A process for denaturing double-stranded nucleic acid comprising the
steps of: applying a voltage to a solution containing said nucleic acid
with an electrode; and converting at least a proportion of said nucleic
acid to a wholly or partially single-stranded form, wherein the solution
contains an effective concentration of a multivalent inorganic cation
acting as a promotor which assists said denaturation.
2. A process as claimed in claim 1, wherein a potential of from -0.5 to
-1.5 V is applied to said electrode with respect to said solution.
3. A process as claimed in claim 2, wherein said voltage is from -0.8 to
-1.1 V.
4. A process as claimed in claim 1, wherein said electrode, a reference
electrode and a counter-electrode are contacted with said solution and a
voltage is applied between said electrode and said counter-electrode so as
to achieve a desired controlled voltage between said electrode and said
reference electrode.
5. A process as claimed in claim 1, wherein the ionic strength of said
solution excluding said promoter is no more than 250 mM.
6. A process as claimed in claim 5, wherein the said ionic strength is no
more than 100 mM.
7. A process as claimed in claim 5, wherein the said ionic strength is no
more than 50 mM.
8. A process as claimed in claim 5, wherein the said ionic strength is no
more than 25 mM.
9. A process as claimed in claim 5, wherein the said ionic strength is no
more than 5 mM.
10. A process as claimed in claim 1, wherein said promoter is magnesium
ions.
11. A process as claimed in claim 1 wherein the concentration of said
promoter cation is from 1 mM to 250 mM.
12. A process as claimed in claim 1, wherein the electrode is of carbon,
gold or platinum.
13. A process as claimed claim 1, carried out at a temperature less than
the melting point of the double-stranded nucleic acid.
14. A process as claimed in claim 13, carried out at about ambient
temperatures.
15. A process as claimed in claim 1 carried out at a pH of from 3 to 10.
16. A process as claimed in claim 15, carried out pH of about 7.
17. A process as claimed in claim 1, wherein the nucleic acid is dissolved
in an aqueous solution containing a buffer whose nature and ionic strength
are such as not to interfere with strand separation of the nucleic acid.
18. A process as claimed in claim 1, wherein said nucleic acid is DNA.
19. A process as claimed in claim 1, wherein said nucleic acid comprises a
DNA strand and an RNA strand.
20. A process as claimed in claim 1, wherein said nucleic acid is a double
stranded RNA.
21. A process as claimed in claim 1, wherein said process is carried out as
a denaturing step in a nucleic acid amplification procedure.
22. A process for amplifying a target sequence of nucleic acid comprising
hybridisation replication and denaturation of nucleic acid, wherein said
denaturation is produced by applying a voltage to a solution containing
said nucleic acid with an electrode wherein the solution contains an
effective concentration of a multivalent inorganic cation acting as a
promoter which assists said denaturation.
23. A process as claimed in claim 22, which is a polymerase chain reaction
amplification process or a ligase chain reaction amplification process.
24. A process for replicating a nucleic acid which comprises: separating
the strands of a sample double stranded nucleic acid in solution to effect
a denaturation under the influence of an electrical voltage applied to the
solution from an electrode; hybridising the separated strands of the
nucleic acid with at least one oligonucleotide primer that hybridises with
at least one of the strands of the denatured nucleic acid; synthesising an
extension product of the or each primer which is sufficiently
complementary to the respective strand of the nucleic acid to hybridise
therewith; and separating the or each extension product from the nucleic
acid strand with which it is hybridised to obtain the extension product
wherein the solution contains an effective concentration of a multivalent
inorganic cation acting as a promoter which assists said denaturation.
25. A process as claimed in claim 24, which further involves repeating the
procedure defined in claim 24 cyclicly.
26. A process as claimed in claim 24, wherein the hybridisation step is
carried out using two primers which are complementary to different strands
of the nucleic acid.
27. A process as claimed in claim 24, wherein the separating to obtain the
extension product is carried out by applying to a solution of the
extension product a voltage from an electrode.
28. A process as claimed in claim 24, for amplifying at least one specific
nucleic acid sequence contained in a nucleic acid or a mixture of nucleic
acids wherein each nucleic acid consists of two separate complementary
strands, of equal or unequal length, which process comprises:
(a) treating the strands with two oligonucleotide primers, for each
different specific sequence being amplified, under conditions such that
for each different sequence being amplified an extension product of each
primer is synthesised which is complementary to each nucleic acid strand,
wherein said primers are selected so as to be substantially complementary
to different strands of each specific sequence such that the extension
product synthesised from one primer, when it is separated from its
complement, can serve as a template for synthesis of the extention product
of the other primer:
(b) separating the primer extension products from the templates on which
they were synthesised to produce single-stranded molecules by applying a
voltage from an electrode to the reaction mixture wherein the reaction
mixture contains an effective concentration of a multivalent inorganic
cation acting as a promoter for said separation: and
(c) treating the single-stranded molecules generated from step (b) with the
primers of step (a) under conditions such that a primer extension product
is synthesised using each of the single strands produced in step (b) as a
template.
29. A process as claimed in claim 23 for amplifying a target nucleic acid
comprising the steps of:
(a) providing nucleic acid of a sample as single-stranded nucleic acid:
(b) providing in the sample at least four nucleic acid probes, wherein: i)
the first and second of said probes are primary probes, and the third and
fourth of said probes are secondary nucleic acid probes; ii) the first
probe is a single strand capable of hybridising to a first segment of a
primary strand of the target nucleic acid; iii) the second probe is a
single strand capable of hybridising to a second segment of said primary
strand of the target nucleic acid; iv) the 5' end of the first segment of
said primary strand of the target is positioned relative to the 3' end of
the second segment of said primary strand of the target to enable joining
of the 3' end of the first probe to the 5' end of the second probe, when
said probes are hybridised to said primary strand of said target nucleic
acid: v) the third probe is capable of hybridising to the first probe; and
iv) the fourth probe is capable of hybridising to the second probe; and
(c) repeatedly or continuously: i) hybridising said probes with nucleic
acid in said sample; ii) ligating hybridised probes to form reorganised
fused probe sequences; and iii) denaturing DNA in said sample by applying
a voltage from an electrode to the reaction mixture, wherein the reaction
mixture contains an effective concentration of a multivalent inorganic
cation acting as a promoter for said separation.
30. A process for detecting the presence or absence of a predetermined
nucleic acid sequence in a sample which comprises: denaturing a sample
double-stranded nucleic acid by means of a voltage applied to the sample
in a solution by means of an electrode, wherein the solution contains an
effective concentration of a multivalent inorganic cation acting as a
promoter which assists said denaturation; hybridising the denatured
nucleic acid with an oligonucleotide probe for the sequence; and
determining whether the said hybridisation has occurred. |
|
|
|
|
Claims  |
|
|
Description  |
|
|
This invention relates to processes for the treatment of nucleic acid
material in order to effect a complete or partial change from double
stranded form to single stranded form and to processes of amplifying or
detecting nucleic acids involving such denaturation processes.
BACKGROUND OF THE INVENTION
Double stranded DNA (deoxyribonucleic acid) and DNA/RNA (ribonucleic acid)
and RNA/RNA complexes in the familiar double helical configuration are
stable molecules that, in vitro, require aggressive conditions to separate
the complementary strands of the nucleic acid. Known methods that are
commonly employed for strand separation require the use of high
temperatures of at least 60.degree. celsius and often 100.degree. celsius
for extended periods of ten minutes or more or use an alkaline pH of 11 or
higher. Other methods include the use of helicase enzymes such as Rep
protein of E. coli that can catalyse the unwinding of the DNA in an
unknown way, or binding proteins such as 32-protein of E.coli phage T4
that act to stabilise the single stranded form of DNA. The denatured
single stranded DNA produced by the known processes of heat or alkali is
used commonly for hybridisation studies or is subjected to amplification
cycles.
U.S. Pat. No. 4,683,202 (Kary B Mullis et al, assigned to Cetus
Corporation) discloses a process for amplifying and detecting a target
nucleic acid sequence contained in a nucleic acid or mixture thereof by
separating the complementary strands of the nucleic acid, hybridising with
specific oligonucleotide primers, extending the primers with a polymerase
to form complementary primer extension products and then using those
extension products for the further synthesis of the desired nucleic acid
sequence by allowing hybridisation with the specific oligonucleotides
primers to take place again. The process can be carried out repetitively
to generate large quantities of the required nucleic acid sequence from
even a single molecule of the starting material. Separation of the
complementary strands of the nucleic acid is achieved preferably by
thermal denaturation in successive cycles, since only the thermal process
offers simple reversibility of the denaturation process to reform the
double stranded nucleic acid, in order to continue the amplification
cycle. However the need for thermal cycling of the reaction mixture limits
the speed at which the multiplication process can be carried out owing to
the slowness of typical heating and cooling systems. It also requires the
use of special heat resistant polymerase enzymes from thermophilic
organisms for the primer extension step if the continuous addition of heat
labile enzyme is to be avoided. It limits the design of new diagnostic
formats that use the amplification process because heat is difficult to
apply in selective regions of a diagnostic device and it also can be
destructive to the structure of the DNA itself because the phosphodiester
bonds may be broken at high temperatures leading to a collection of broken
single strands. It is generally believed that the thermophilic polymerases
in use today have a lower fidelity ie. make more errors in copying DNA
than do enzymes from mesophiles. It is also the case that thermophilic
enzymes such as TAQ polymerase have a lower turnover number than heat
labile enzymes such as the Klenow polymerase from E.coli. In addition, the
need to heat to high temperatures, usually 90.degree. celsius or higher to
denature the nucleic acid leads to complications when small volumes are
used as the evaporation of the liquid is difficult to control. These
limitations have so far placed some restrictions on the use of the Mullis
et al process in applications requiring very low reagent volumes to
provide reagent economy, in applications where the greatest accuracy of
copy is required such as in the Human Genome sequencing project and in the
routine diagnostics industry where reagent economy, the design of the
assay format and the speed of the DNA denaturation/renaturation process
are important.
Denaturation/renaturation cycles are also required in order to perform the
so-called ligase chain reaction described in EP-A-0320308 in which
amplification is obtained by ligation of primers hybridised to template
sequences rather than by extending them.
It is known that DNA has electrochemical properties. For example, N. L.
Palacek (in "Electrochemical Behaviour of Biological Macromolecules",
Bioelectrochemistry and Bioenergetics, 15, (1986), 275-295) discloses the
electrochemical reduction of adenine and cytosine in thermally denatured
single stranded DNA at about -(minus) 1.5 V on the surface of a mercury
electrode. This reduction process also requires a prior protonation and
therefore takes place at a pH below 7.0. The primary reduction sites of
adenine and cytosine form part of the hydrogen bonds in the Watson-Crick
base pairs. Palacek was unable to demonstrate reduction of adenine and
cytosine in intact, native double stranded DNA at the mercury electrode.
Palacek has further demonstrated that to a very limited extent the DNA
double helix is opened on the surface of the mercury electrode at a narrow
range of potentials centred at -(minus)1.2 V in a slow process involving
an appreciable part of the DNA molecule. This change in the helical
structure of the DNA is thought to be due to prolonged interaction with
the electrode charged to certain potentials and is not thought to be a
process involving electron transfer to the DNA. No accumulation of single
stranded DNA in the working solution was obtained and no practical utility
for the phenomenon was suggested. Palacek also reports that the guanine
residues in DNA can be reduced at -(minus)1.8 V to dihydroguanine which
can be oxidised back to guanine at around -(minus)0.3 V. The reducible
guanine double bond is not part of the hydrogen bonds in the Watson-Crick
base pairs and this electrochemical process involving guanine does not
affect the structure of the DNA double helix.
In an earlier paper F. Jelen and E. Palacek (in "Nucleotide
Sequence-Dependent Opening of Double-Stranded DNA at an Electrically
Charged Surface", Gen. Physiol. Biophys., (1985), 4, pp 219-237), describe
in more detail the opening of the DNA double helix on prolonged contact of
the DNA molecules with the surface of a mercury electrode. The mechanism
of opening of the helix is postulated to be anchoring of the
polynucleotide chain via the hydrophobic bases to the electrode surface
after which the negatively charged phosphate residues of the DNA are
strongly repelled from the electrode surface at an applied potential close
to -(minus)1.2 V, the strand separation being brought about as a result of
the electric field provided by the cathode. There is no disclosure of
separating the strands of the DNA double helix while the DNA is in
solution (rather than adsorbed onto the electrode) and there is no
disclosure of useful amounts of single strand DNA in solution.
Furthermore, there is no disclosure that the nucleotide base sequence of
the DNA on the electrode is accessible from solution. The bases themselves
are tightly bound to the mercury surface. A mercury electrode is a complex
system and the electrode can only be operated in the research laboratory
with trained technical staff.
H W Nurnberg ("Applications of Advanced Voltammetric Methods in
Electrochemistry" in "Bioelectrochemistry", Plenum Inc (New York), 1983,
pp. 183-225) discloses partial helix opening of adsorbed regions of native
DNA to a mercury electrode surface to form a so-called ladder structure.
However, the DNA is effectively inseparably bound to or adsorbed onto the
electrode surface. In this condition, we believe the denatured DNA to be
of no use for any subsequent process of amplification or analysis. To be
of any use, the denatured DNA must be accessible to subsequent processes
and this is conveniently achieved if the single stranded DNA is available
in free solution or is associated with the electrode in some way but
remains accessible to further processes. Nurnberg has not demonstrated the
ability of the mercury electrode to provide useful quantities of single
stranded DNA.
V. Brabec and K. Niki ("Raman scattering from nucleic acids adsorbed at a
silver electrode" in Biophysical Chemistry (1985), 23, pp 63-70) have
provided a useful summary of the differing views from several workers on
DNA denaturation at the surface of both mercury and graphite electrodes
charged to negative potentials. There has emerged a consensus amongst the
research workers in this field that the denaturation process only takes
place in DNA that is strongly adsorbed to the electrode surface and only
over prolonged periods of treatment with the appropriate negative voltage,
a positive voltage having no effect on the double helix.
Brabec and Palacek (J. Electroanal. Chem., 88 (1978) 373-385) disclose that
sonicated DNA damaged by gamma radiation is transiently partially
denatured on the surface of a mercury pool electrode, the process being
detectable by reacting the single stranded products with formaldehyde so
as to accumulate methylated DNA products in solution. Intact DNA did not
show any observable denaturation.
Our Application No. PCT/GB91/01563 discloses a process for denaturing
double-stranded nucleic acid which comprises operating on solution
containing nucleic acid with an electrode under conditions such as to
convert a substantial portion of said nucleic acid to a wholly or
partially single stranded form.
This process was based on a finding that it is possible to produce the
denaturation of undamaged (i.e. non-irradiated) DNA at ambient temperature
by applying a suitable voltage to a solution in which the DNA is present
under suitable conditions.
The mechanism for the process has not yet been fully elucidated. We believe
that the process is one in which the electric field at the electrode
surface which produces the denaturation of the double helix.
In polymerase chain reaction processes, it has been shown that the
denatured DNA produced by the denaturing process is immediately in a
suitable state for primer hybridisation and extension. On a larger scale,
it has been found that samples of denatured DNA produced either by a
negative voltage electrode or thermal denaturation can be caused or
encouraged to reanneal by incubation at a higher temperature or by the use
of a positive voltage.
Although the process of Application No. PCT/GB91/01563 can take place in a
solution containing only the electrode and the nucleic acid dissolved in
water containing a suitable buffer, the process can be facilitated by the
presence in the solution containing the nucleic acid of a promoter
compound. Methyl viologen or a salt thereof was disclosed as the preferred
promoter compound.
It is believed that the positively charged viologen molecules interact
between the negatively charged DNA and the negatively charged cathode to
reduce electrostatic repulsion therebetween and hence to promote the
approach of the DNA to the electrode surface where the electrical field is
at its strongest. Accordingly, we expressed a preference in Application
No. PCT/GB91/01563 to employ as promoters compounds having spaced
positively charged centres, e.g. bipolar positively charged compounds.
Preferably, the spacing between the positively charged centres was to be
similar to that in viologens.
SUMMARY OF THE INVENTION
We have now discovered that multivalent inorganic cations, preferably
Mg.sup.2+, can also act as promoters in such a system with approximately
the same efficacy as methyl viologen.
It is thought that large cations such as Mg.sup.2+ are able to act as a
bridge between a negative electrode and negatively charged regions of the
double-stranded nucleic acid.
Accordingly, the present invention provides a process for denaturing
double-stranded nucleic acid which comprises operating on solution
containing said nucleic acid with an electrode under condition such as to
convert a substantial proportion of said nucleic acid to a wholly or
partially single stranded form wherein the solution contains an effective
concentration of a multivalent inorganic cation acting as a promoter which
assists said denaturation.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The cations used as the promoter may include inorganic cations complexed
with inorganic or organic ligands, e.g. Pt(NH.sub.3).sub.6 .sup.4+ and
Cr(NH.sub.3).sub.6 .sup.2+ but the preferred cation is Mg.sup.2+.
Mixtures of promoter cations may be employed.
The concentration of said promoter cation is preferably from 1 mM to 250
mM, more preferably from 70 mM, e.g. about 100 mM.
Preferably, according to the invention, the single stranded nucleic acid
produced is free from the electrode, e.g. in solution. However, the
nucleic acid may be immobilised on the electrode in double or single
stranded form prior to the application of the electric potential, e.g.
attached by the end or a small portion intermediate the ends of the
nucleic acid chain, so as to leave substantial segments of the nucleic
acid molecules freely pendant from the electrode surface before and after
denaturation.
In addition to said electrode and a counter-electrode, a reference
electrode may be contacted with said solution and a voltage may be applied
between said electrode and said counter-electrode so as to achieve a
desired controlled voltage between said electrode and said reference
electrode. The electrodes may be connected by a potentiostat circuit as is
known in the electrochemical art.
Preferably, a potential of from -0.5 to -1.5 V is applied to said working
electrode with respect to said reference electrode, more preferably from
-0.8 to -1.1 V, e.g. about -1.0 V.
Working electrode voltages are given throughout as if measured or as
actually measured relative to a calomel reference electrode (BDH No.
309.1030.02).
The ionic strength of said solution is preferably no more than 250 mM, more
preferably no more than 100 mM. As it has been found that the rate of
denaturation increases as the ionic strength is decreased, the said ionic
strength is still more preferably no more than 50 mM, e.g. no more than 25
mM or even no more than 5 mM. Generally, the lower the ionic strength, the
more rapid is the denaturation. However, in calculating ionic strength for
these purposes it may be appropriate to ignore one contribution to ionic
strength of any component which acts as a promoter as described above.
The process may be carried out in an electrochemical cell of the type
described by C. J. Stanley, M. Cardosi and A. P. F Turner "Amperometric
Enzyme Amplified Immunoassays" J. Immunol. Meth (1988) 112, 153-161 in
which there is a working electrode, a counter electrode and optionally a
reference electrode. The working electrode at or by which the denaturing
nucleic acid is effected may be of any convenient material e.g. a noble
metal such as gold or platinum, or a glassy carbon electrode.
The electrode may be a so called "modified electrode" in which the
denaturing is promoted by a compound coated onto, or adsorbed onto, or
incorporated into the structure of the electrode which is otherwise of an
inert but conducting material. In an alternative electrochemical cell
configuration the working, counter and reference electrodes may be formed
on a single surface e.g. a flat surface by any printing method such as
thick film screen printing, ink jet printing, or by using a photo-resist
followed by etching. It is also possible that the counter and reference
electrodes can be combined on the flat surface leading to a two electrode
configuration. Alternatively the electrodes may be formed on the inside
surface of a well which is adapted to hold liquid such a well could be the
well known 96 well or Microtitre plate, it may also be a test tube or
other vessel. Electrode arrays in Microtitre plates or other moulded or
thermoformed plastic materials may be provided for multiple nucleic acid
denaturation experiments.
The strand separation may be carried out in an aqueous medium or in a
mixture of water with an organic solvent such as dimethylformamide. The
use of polar solvents other than water or non-polar solvents is also
acceptable but is not preferred. The process may be carried out at ambient
temperatures or if desired temperatures up to adjacent the pre-melting
temperature of the nucleic acid. The process may be carried out at pH's of
from 3 to 10 conveniently about 7. Generally, more rapid denaturation is
obtained at lower pH. For some purposes therefore a pH somewhat below
neutral, e.g about pH 5.5 may be preferred. The nucleic acid may be
dissolved in an aqueous solution containing a buffer whose nature and
ionic strength are such as not to interfere with the strand separation
process.
The denaturing process according to the invention may be incorporated as a
step in a number of more complex processes, e.g. procedures involving the
analysis and or the amplification of nucleic acid. Some examples of such
applications are described below.
The invention includes a process for detecting the presence or absence of a
predetermined nucleic acid sequence in a sample which comprises:
denaturing a sample double-stranded nucleic acid by means of a voltage
applied to the sample in a solution by means of an electrode; hybridising
the denatured nucleic acid with an oligonucleotide probe for the sequence;
and determining whether the said hybridisation has occurred, wherein
during denaturing the solution contains an effective concentration of a
multivalent inorganic cation acting as a promoter which assists said
denaturation.
Thus, the invented process has application in DNA and RNA hybridisation
where a specific gene sequence is to be identified e.g. specific to a
particular organism or specific to a particular hereditary disease of
which sickle cell anaemia is an example. To detect a specific sequence it
is first necessary to prepare a sample of DNA, preferably of purified DNA,
means for which are known, which is in native double stranded form. It is
then necessary to convert the double stranded DNA to single stranded form
before a hybridisation step with a labelled nucleotide probe which has a
complementary sequence to the DNA sample can take place. The denaturation
process of the invention can be used for this purpose in a preferred
manner by carrying out the following steps:
denaturing a sample of DNA by applying a voltage by means of an electrode
to the sample DNA with a said promoter in solution;
hybridising the denatured DNA with a directly labelled or indirectly
labelled nucleotide probe complementary to the sequence of interest; and
determining whether the hybridisation has occurred, which determination may
be by detecting the presence of the probe, the probe being directly
radio-labelled, fluorescent labelled, chemiluminescent labelled or
enzyme-labelled or being an indirectly labelled probe which carries biotin
for example to which a labelled avidin or avidin type molecule can be
bound later.
In a typical DNA probe assay it is customary to immobilise the sample DNA
to a membrane surface which may be composed of neutral or charged nylon or
nitrocellulose. The immobilisation is achieved by charge interactions or
by baking the membrane containing DNA in an oven. The sample DNA can be
heated to high temperature to ensure conversion to single stranded form
before binding to the membrane or it can be treated with alkali once on
the membrane to ensure conversion to the single stranded form. The
disadvantages of the present methods are:
heating to high temperatures to create single stranded DNA can cause damage
to the sample DNA itself.
the use of alkali requires an additional step of neutralisation before
hybridisation with the labelled probe can take place.
One improved method for carrying out DNA probe hybridisation assays is the
so called "sandwich" technique where a specific oligonucleotide is
immobilised on a surface. The surface having the specific oligonucleotide
thereon is then hybridised with a solution containing the target DNA in a
single-stranded form, after which a second labelled oligonucleotide is
then added which also hybridises to the target DNA. The surface is then
washed to remove unbound labelled oligonucleotide, after which any label
which has become bound to target DNA on the surface can be detected later.
This procedure can be simplified by using the denaturing process of the
invention to denature the double-stranded DNA into the required
single-stranded DNA. The working electrode, counter electrode and
optionally a reference electrode and/or the promoter can be incorporated
into a test tube or a well in which the DNA probe assay is to be carried
out. The DNA sample, promoter if not already present and oligonucleotide
probes can then be added and the voltage applied to denature the DNA. The
resulting single-stranded DNA is hybridised with the specific
oligonucleotide immobilised on the surface after which the remaining
stages of a sandwich assay are carried out. All the above steps can take
place without a need for high temperatures or addition of alkali reagents
as in the conventional process.
The electrochemical denaturation of DNA can be used in the amplification of
nucleic acids, e.g. in a polymerase chain reaction or ligase chain
reaction amplification procedure. Thus the present invention provides a
process for replicating a nucleic acid which comprises: separating the
strands of a sample double stranded nucleic acid in solution under the
influence of an inorganic multivalent cation promoter and an electrical
voltage applied to the solution from an electrode; hybridising the
separated strands of the nucleic acid with at least one oligonucleotide
primer that hybridises with at least one of the strands of the denatured
nucleic acid; synthesising an extension product of the or each primer
which is sufficiently complementary to the respective strand of the
nucleic acid to hybridise therewith; and separating the or each extension
product from the nucleic acid strand with which it is hybridised to obtain
the extension product.
In such a polymerase mediated replication procedure, e.g. a polymerase
chain reaction procedure, it may not be necessary in all cases to carry
out denaturation to the point of producing wholly single-stranded
molecules of nucleic acid. It may be sufficient to produce a sufficient
local and/or temporary weakening or separation of the double helix in the
primer hybridisation site to allow the primer to bind to its target. Once
the primer is in position on a first of the target strands,
rehybridisation of the target strands in the primer region will be
prevented and the other target strands may be progressively displaced by
extension of the primer or by further temporary weakening or separation
processes.
Preferably, the said amplification process further comprises repeating the
procedure defined above cyclicly, e.g. for more than 10 cycles, e.g. up to
20 or 30 cycles. In the amplification process the hybridisation step is
preferably carried out using two primers which are complementary to
different strands of the nucleic acid.
The denaturation to obtain the extension products as well as the original
denaturing of the target nucleic acid is preferably carried out by
applying to the solution of the nucleic acid a voltage from an electrode,
the solution containing a promoter as described therein.
The process may be a standard or classical PCR process for amplifying at
least one specific nucleic acid sequence contained in a nucleic acid or a
mixture of nucleic acids wherein each nucleic acid consists of two
separate complementary strands, of equal or unequal length, which process
comprises:
(a) treating the strands with two oligonucleotide primers, for each
different specific sequence being applied, under conditions such that for
each different sequence being amplified an extension product of each
primer is synthesised which is complementary to each nucleic acid strand,
wherein said primers are selected so as to be substantially complementary
to different strands of each specific sequence such that the extension
product synthesised from one primer, when it is separated from its
complement, can serve as a template for synthesis of the extension produce
of the other primer:
(b) separating the primer extension products from templates on which they
were synthesised to produce single-stranded molecules in the presence of a
said promoter by applying a voltage from an electrode to the reaction
mixture: and
(c) treating the single-stranded molecules generated from step (b) with the
primers of step (a) under conditions such that a primer extension product
is synthesised using each of the single strands produced in step (b) as a
template.
Alternatively, the process may be any variant of the classical or standard
PCR process, e.g. the so-called "inverted" or "inverse" PCR process or the
"anchored" PCR process.
The invention therefore includes an amplification process as described
above in which a primer is hybridised to a circular nucleic acid and is
extended to form a duplex which is denatured by the denaturing process of
the invention, the amplification process optionally being repeated through
one or more additional cycles.
More generally, the invention includes a process for amplifying a target
sequence of nucleic acid comprising hybridisation, amplification and
denaturation of nucleic acid (e.g. cycles of hybridising and denaturing)
wherein said denaturation is produced by operating on a solution
containing said nucleic acid with an electrode in the presence of an
inorganic multivalent cation promoter.
The process of the invention is applicable to the ligase chain reaction.
Accordingly, the invention includes a process for amplifying a target
nucleic acid comprising the steps of:
(a) providing nucleic acid of a sample as single-stranded nucleic acid;
(b) providing in the sample at least four nucleic acid probes, wherein: i)
the first and second of said probes are primary probes, and the third and
fourth of said probes are secondary nucleic acid probes; ii) the first
probe is a single strand capable of hybridising to a first segment of a
primary strand of the target nucleic acid; iii) the second probe is a
single strand capable of hybridising to a second segment of said primary
strand of the target nucleic acid; iv) the 5' end of the first segment of
said primary strand of the target is positioned relative to the 3' end of
the second segment of said primary strand of the target to enable joining
of the 3' end of the first probe to the 5' end of the second probe, when
said probes are hybridised to said primary strand of said target nucleic
acid; v) the third probe is capable of hybridising to the first probe; and
iv) the fourth probe is capable of hybridising to the second probe; and
(c) repeatedly or continuously: i) hybridising said probes with nucleic
acid in said sample; ii) ligating hybridised probes to form reorganised
fused probe sequences; and iii) denaturing DNA in said sample by applying
a voltage from an electrode to the reaction mixture in the presence of a
said promoter.
In all of the amplification procedures described above the denaturation of
the DNA to allow subsequent hybridisation with the primers can be carried
out by the application of an appropriate potential to the electrode. The
process may be carried out stepwise involving successive cycles of
denaturation or renaturation as in the existing thermal methods of PCR and
LCR, but it is also possible for it to be carried out continuously since
the process of chain extension or ligation by the enzyme and subsequent
strand separation by the electrochemical process can continue in the same
reaction as nucleic acid molecules in single-stranded form will be free to
hybridise with primers once they leave the denaturing influence of the
electrode. Thus, provided that the primer will hybridise with the DNA an
extension or ligation product will be synthesised. The electrochemical DNA
amplification technique can be used analytically to detect and analyse a
very small sample of DNA eg a single copy gene in an animal cell or a
single cell of a bacterium.
The invention includes a kit for use in a process of detecting the presence
or absence of a predetermined nucleic acid sequence in a sample which kit
comprises, an electrode, a counter electrode and optionally a reference
electrode, an oligonucleotide probe for said sequence and a source of an
inorganic multivalent cation for use as a promoter in obtaining nucleic
acid strand separation at said electrode. The probe may be labelled in any
of the ways discussed above.
The invention also includes a kit for use in a process of nucleic acid
amplification comprising an electrode, a counter electrode and optionally
a reference electrode, and a source of an inorganic multivalent cation for
use as a promoter in obtaining nucleic acid strand separation at said
electrode and at least one primer for use in a PCR procedure, or at least
one primer for use in an LCR procedure, and/or a polymerase or a ligase,
and/or nucleotides suitable for use in a PCR process.
Preferably, such kits includes a cell containing the electrodes. Preferably
the kits include a suitable buffer for use in the detection or
amplification procedure.
BRIEF DESCRIPTION OF THE DRAWING
The invention will now be described with reference to the following
drawings and examples.
FIG. 1 is a diagram of an electrochemical cell used for denaturation of DNA
.
In FIG. 1 there is shown a cell structure 10 comprising a working
compartment 12 in which there is a body of DNA-containing solution, a
working electrode 14, a counter electrode 16, a FiVac seal 19, a Kwik fit
adaptor 21 and a magnetic stirrer 18. A reference electrode 20 in a
separate side arm is connected via a "luggin" capillary 23 to the solution
in the working compartment 12. The working electrode, counter electrode
and reference electrode are connected together in a potentiostat
arrangement so that a constant voltage is maintained between the working
electrode 14 and the reference electrode 20. Such potentiostat
arrangements are well known (see for example "Instrumental Methods in
Electrochemistry" by The Southampton Electrochemistry Group, 1985, John
Wiley and Sons, p 19).
The electrode 14 is a circular glassy carbon rod of diameter 0.5 cm,
narrowing to 0.25 cm at a height of 10 mM, and having an overall length of
9 cm inside a teflon sleeve of outside diameter 0.8 cm (supplied by Oxford
Electrodes, 18 Alexander Place, Abingdon, Oxon), and the reference
electrode 16 is a 2 mm pin calomel (supplied by BDH No 309/1030/02). The
counter electrode is supported by a wire which is soldered to a brass
sleeve 25 above the adaptor and passes down and exits the teflon sleeve 20
mm from the base of the working electrode. The wire attaches to a
cylindrical platinum mesh counter-electrode supplied by Oxford Electrodes
which annularly surrounds the working electrode.
This cell is used in the following examples.
EXAMPLE 1
To the working chamber of the cell shown in FIG. 1 was added 900 .mu.l of
distilled water and 40 .mu.g/ml of Calf Thymus DNA together with the
promoter shown in Table 1 below. The contents of the cell were subjected
to -1.0 V for up to 4 hours.
Samples were taken at 0, 30 mins, 1 hr, and 2 hrs. from commencement and
analysed on 1% agarose gel to observe the degree of denaturation. Results
were as shown in Table 1.
______________________________________
Time for
Promoter complete
Run Promoter Concentration
denaturation
______________________________________
1 Mg Cl.sub.2
10 mM >4 hrs
2 Mg Cl.sub.2
30 mM >4 hrs
3 Mg Cl.sub.2
100 mM 1-2 hours
Control Methyl 30 mg/ml 1-2 hours
Viologen (120 mM
approx)
______________________________________
Thus it can be seen that in this system a minimum effective amount of
Mg.sup.2+ as a promoter lies between 30 and 100 mM and that Mg.sup.2+ is
approximately as effective as a promoter as methyl viologen.
* * * * *
|
|
|
|
|
Description  |
|